DCM
Driehaus Capital Management Portfolio holdings
AUM
$14.7B
1-Year Est. Return
125.87%
This Fund
S&P 500
1 Year Est. Return
+125.87%
AUM
$14.7B
AUM Growth
+$761M
(+5.4%)
Holding
518
Top Buys
| 1 | +$111M | |
| 2 | +$93.9M | |
| 3 | +$80.5M | |
| 4 |
Fomento Económico Mexicano
FMX
|
+$65.4M |
| 5 |
Nu Holdings
NU
|
+$59.3M |
Top Sells
| 1 | +$138M | |
| 2 | +$120M | |
| 3 | +$84M | |
| 4 |
Ollie's Bargain Outlet
OLLI
|
+$76.8M |
| 5 |
Credo Technology Group
CRDO
|
+$75.9M |
Sector Composition
| 1 | Healthcare | 29.41% |
| 2 | Industrials | 21.41% |
| 3 | Technology | 18.1% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Financials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Arrowhead Research
ARWR
$9.96B
| $117M | 0.8% |
1,769,340
-330,058
|
|
||
27
Structure Therapeutics
GPCR
$3.26B
| $114M | 0.78% |
1,642,444
+768,940
|
|
||
28
Wave Life Sciences
WVE
$1.39B
| $112M | 0.76% |
6,581,067
+283,007
|
|
||
29
Fabrinet
FN
$25.1B
| $110M | 0.75% |
240,978
-132,458
|
|
||
30
Weatherford International
WFRD
$7.2B
| $108M | 0.74% |
1,384,142
+419,961
|
|
||
31
Uranium Energy
UEC
$7.19B
| $106M | 0.72% |
9,112,072
-375,744
|
|
||
32
Edgewise Therapeutics
EWTX
$3.52B
| $104M | 0.71% |
4,191,193
+1,962,908
|
|
||
|
EMBJ
33
Embraer S.A. ADS
EMBJ
$11.9B
| $102M | 0.7% |
1,590,028
+661,071
|
|
||
|
KRMN
34
Karman Holdings
KRMN
$10.9B
| $99.2M | 0.67% |
1,355,169
-198,479
|
|
||
35
Protagonist Therapeutics
PTGX
$6.74B
| $96M | 0.65% |
1,099,170
-40,684
|
|
||
36
Tarsus Pharmaceuticals
TARS
$2.72B
| $96M | 0.65% |
1,172,427
+141,386
|
|
||
37
Carvana
CVNA
$57.5B
| $95.8M | 0.65% |
226,963
-90,945
|
|
||
38
Spyre Therapeutics
SYRE
$6.17B
| $94.4M | 0.64% |
2,882,420
+822,045
|
|
||
39
Crane Co
CR
$10.9B
| $93.3M | 0.63% |
505,668
-32,677
|
|
||
40
National Vision
EYE
$2.03B
| $93.1M | 0.63% |
3,606,811
+1,350,811
|
|
||
41
VSE Corp
VSEC
$5.66B
| $89.9M | 0.61% |
520,237
+182,544
|
|
||
42
Rambus
RMBS
$14.1B
| $87.7M | 0.6% |
+954,164
|
|
||
|
DFTX
43
Definium Therapeutics
DFTX
$2.35B
| $87.5M | 0.59% |
6,537,202
+3,427,291
|
|
||
44
Transmedics
TMDX
$3.79B
| $86.6M | 0.59% |
712,041
-26,117
|
|
||
45
PTC Therapeutics
PTCT
$5.92B
| $86.3M | 0.59% |
1,136,188
+4,439
|
|
||
46
Scholar Rock
SRRK
$5.53B
| $86M | 0.58% |
1,952,877
-71,082
|
|
||
47
SPX Corp
SPXC
$10.8B
| $86M | 0.58% |
429,764
+154,388
|
|
||
48
Itaú Unibanco
ITUB
$101B
| $84.9M | 0.58% |
11,857,114
+948,720
|
|
||
49
Kymera Therapeutics
KYMR
$7.08B
| $83.2M | 0.57% |
1,069,238
+130,144
|
|
||
50
Coherent
COHR
$65.2B
| $82.7M | 0.56% |
447,945
+9,093
|
|